Prosecution Insights
Last updated: October 25, 2026

University of Central Florida Research Foundation Inc.

Technology areas: Biotechnology & Pharmaceuticals • Chemistry & Materials • Semiconductors, Circuits & Optics

22 pending office actions • 20 art units • 22 examiners • 0 of 22 (0%) have an AI response strategy ready • 60 patents granted in the last 365 days

Analysis

University of Central Florida Research Foundation Inc. has 20 pending office actions in Biotechnology & Pharmaceuticals. The matters involve 20 distinct examiners across 17 distinct art units, indicating that examiner assignments are fully separated while several art units receive multiple matters.

WARMFLASH, MICHAEL J is the busiest examiner, with 1 pending matter. The data does not show a dominant examiner concentration, so counsel may need a portfolio process that preserves matter-specific analysis while grouping work by art unit where repeated examination conditions may arise.

Written from this page's own data; every figure is computed from USPTO records and verified before publication.

Portfolio Summary

22
Total Pending OAs
10
Non-Final OAs
11
Final Rejections
1
Advisory / Quayle

Response Deadline Pressure

Based on the USPTO statutory response window for each pending office action. 8 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.

2
Overdue
1
Due this week
2
Due this month
1
Due in next 60 days
2
Due later

Deadline Fire Line

Every pending office action with a known statutory deadline, placed on a days-until-due axis. Dots left of Today are overdue; the further right, the more runway. Cases that share a deadline window stack vertically. 8 of the docket's apps have a known mailing date.

-30dToday30d60d90d120d
Overdue (2)Due ≤ 7 days (1)Due ≤ 30 days (2)Due ≤ 60 days (1)Due later (2)

Case Difficulty Mix

Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.

14
Hard (64%)
7
Medium (32%)
1
Easy (5%)
0
Unknown (0%)

Rejection Statute Mix

BucketCases
§101 + other1 (5%)
§103 only7 (32%)
§112 only1 (5%)
Multi-statute (no §101)13 (59%)

Industry Mix

How the docket's pending cases split across USPTO tech-center bands.

10
Life Sciences
45% of docket
1
Information Tech
5% of docket
0
Communications
0% of docket
6
Semiconductors
27% of docket
5
Mechanical / Eng
23% of docket
0
Business / Other
0% of docket

Time-on-OA Estimate

Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.

220 h
Manual time on pending OAs
44 h
Time saved (low, 20%)
77 h
Time saved (mid, 35%)
1.9 wks
FTE-weeks freed (mid)

Top Examiners on this docket

ExaminerApps on this docketAllow rateInterview lift
WARMFLASH, MICHAEL J 1 80.7% +21.0%
NIA, ALIREZA 1 41.7% +49.5%
KUMAR, KALYANAVENKA K 1 72.9% +18.3%
HUANG, RYAN 1 53.1% +31.1%
TINSLEY, BRENDAN THOMAS 1 60.4% +74.3%
NYAMOGO, JOSEPH A 1 67.1% +28.5%
HENDRICKSON, STUART L 1 72.4% +8.1%
SAHLE, MAHIDERE S 1 79.5% +13.1%
SUN, CAITLYN MINGYUN 1 63.7% +11.8%
CRUM, VIVIAN FLORENCE 1 100.0% +0.0%

Hard Cases (14)

Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 8 ordered by deadline are shown.

App #TitleExaminerDue in
18372646 SYSTEM AND METHOD FOR USING AMMONIA AS A FUEL SOURCE FOR ENGINES IGUE, ROBERTO TOSHIHARU 5d overdue
18276929 CORONAL PROTEIN-COATED NANOPARTICLES AND USES THEREOF BAEK, BONG-SOOK 6d
19173866 SYSTEM FOR EXTRACTING WATER FROM LUNAR REGOLITH AND ASSOCIATED METHOD KUMAR, KALYANAVENKA K 26d
18532629 BEAM COMBINING USING ROTATED VOLUME BRAGG GRATINGS LEE, PAUL CHANG 60d
18121401 INTERMOLECULARLY-FABRICATED COMPOSITION FOR ENCAPSULATING PLANT MATERIALS, AGROCHEMICALS AND PHARMACEUTICALS BOYLE, ROBERT C 70d
17920942 CD25-TARGETED IL-2 FOR INCREASING CD4 T CELL FORMATION AND TREATMENT OF INFECTIONS CARTER, SANDRA DILLAHUNT 70d
19270956 INTEGRATED MULTIPORT HYBRID MICROINVERTER WARMFLASH, MICHAEL J —
19226100 SYSTEM AND METHOD FOR PAIN SUPPRESSION WITH COOLING NIA, ALIREZA —

Interview Candidates (8)

Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 8 ordered by deadline are shown.

App #TitleExaminerDue in
18412083 STRESS-CONTROLLED DEFECT ENGINEERING IN CERIA NANOSTRUCTURES SUN, CAITLYN MINGYUN 16d overdue
18615915 SERIAL ARRAY OF MODULATORS AND DETECTORS SAHLE, MAHIDERE S 19d
19173866 SYSTEM FOR EXTRACTING WATER FROM LUNAR REGOLITH AND ASSOCIATED METHOD KUMAR, KALYANAVENKA K 26d
19270956 INTEGRATED MULTIPORT HYBRID MICROINVERTER WARMFLASH, MICHAEL J —
19226100 SYSTEM AND METHOD FOR PAIN SUPPRESSION WITH COOLING NIA, ALIREZA —
18830799 NANOFILTRATION SYSTEM AND METHOD INCLUDING PRETREATMENT WITH GREEN SORPTION MEDIA HUANG, RYAN —
18838734 ANABOLIC DRUGS STIMULATING TYPE II COLLAGEN PRODUCTION FROM CHONDROCYTES OR THEIR PROGENITORS TINSLEY, BRENDAN THOMAS —
18653408 DETECTION AND IDENTIFICATION OF WEAK SIGNALS IN A NOISY ENVIRONMENT NYAMOGO, JOSEPH A —

Top Art Units

Art UnitApps
2872 2
1674 2
2836 1
3786 1
3653 1
1778 1
1634 1
2858 1
1736 1
1795 1

Pending Office Actions

App #TitleExaminerArt UnitStatutesStatusDue inAIFiled
19270956 INTEGRATED MULTIPORT HYBRID MICROINVERTER WARMFLASH, MICHAEL J 2836 §102§103 Non-Final OA — Pending Jul 16, 2025
19226100 SYSTEM AND METHOD FOR PAIN SUPPRESSION WITH COOLING NIA, ALIREZA 3786 §102§103§112 Non-Final OA — Pending Jun 02, 2025
19173866 SYSTEM FOR EXTRACTING WATER FROM LUNAR REGOLITH AND ASSOCIATED METHOD KUMAR, KALYANAVENKA K 3653 §102§103§112 Final Rejection 26d Pending Apr 09, 2025
18830799 NANOFILTRATION SYSTEM AND METHOD INCLUDING PRETREATMENT WITH GREEN SORPTION MEDIA HUANG, RYAN 1778 §103§112 Non-Final OA — Pending Sep 11, 2024
18838734 ANABOLIC DRUGS STIMULATING TYPE II COLLAGEN PRODUCTION FROM CHONDROCYTES OR THEIR PROGENITORS TINSLEY, BRENDAN THOMAS 1634 §103 Non-Final OA — Pending Aug 15, 2024
18653408 DETECTION AND IDENTIFICATION OF WEAK SIGNALS IN A NOISY ENVIRONMENT NYAMOGO, JOSEPH A 2858 §103 Non-Final OA — Pending May 02, 2024
18646475 DYNAMIC DIALYSIS AS SCALABLE MANUFACTURING OF PURIFIED SURFACE ACTIVE MULTI-COMPONENT NANOPARTICLE PRODUCTION HENDRICKSON, STUART L 1736 §102§103§112 Non-Final OA — Pending Apr 25, 2024
18615915 SERIAL ARRAY OF MODULATORS AND DETECTORS SAHLE, MAHIDERE S 2872 §103 Final Rejection 19d Pending Mar 25, 2024
18412083 STRESS-CONTROLLED DEFECT ENGINEERING IN CERIA NANOSTRUCTURES SUN, CAITLYN MINGYUN 1795 §103 Non-Final OA 16d overdue Pending Jan 12, 2024
18535535 HIGH EFFICIENCY SURFACE LIGAND EXCHANGE METHODOLOGY FOR HIGH THROUGHPUT PRODUCTION OF PURIFIED DISPERSION COLLOIDAL METAL OXIDES CRUM, VIVIAN FLORENCE 1738 §103§112 Final Rejection — Pending Dec 11, 2023
18532629 BEAM COMBINING USING ROTATED VOLUME BRAGG GRATINGS LEE, PAUL CHANG 2871 §102§103 Final Rejection 60d Pending Dec 07, 2023
18372646 SYSTEM AND METHOD FOR USING AMMONIA AS A FUEL SOURCE FOR ENGINES IGUE, ROBERTO TOSHIHARU 3741 §103§112 Final Rejection 5d overdue Pending Sep 25, 2023
18456258 UNKNOWN-CLASS (OUT-OF-DISTRIBUTION) DATA DETECTION IN MACHINE LEARNING MODELS JUNG, DONG YOON 2145 §103 Final Rejection — Pending Aug 25, 2023
18276929 CORONAL PROTEIN-COATED NANOPARTICLES AND USES THEREOF BAEK, BONG-SOOK 1611 §102§103§112 Final Rejection 6d Pending Aug 11, 2023
18321149 APPENDAGE WORK SHARING APPARATUS CALLISON, KEIRA EILEEN 3785 §102§103 Non-Final OA — Pending May 22, 2023
18121401 INTERMOLECULARLY-FABRICATED COMPOSITION FOR ENCAPSULATING PLANT MATERIALS, AGROCHEMICALS AND PHARMACEUTICALS BOYLE, ROBERT C 1764 §102§103 Final Rejection 70d Pending Mar 14, 2023
18026222 USE OF LONG NON-CODING RNAS IN MEDULLOBLASTOMA MEYERING, SHABANA SHABBEER 1635 §101§102§112Other Non-Final OA — Pending Mar 14, 2023
18101483 REFLECTIVE HOLOGRAPHIC PHASE MASKS DEAN, RAY ALEXANDER 2872 §103 Non-Final OA — Pending Jan 25, 2023
17920942 CD25-TARGETED IL-2 FOR INCREASING CD4 T CELL FORMATION AND TREATMENT OF INFECTIONS CARTER, SANDRA DILLAHUNT 1674 §102§112 Final Rejection 70d Pending Oct 24, 2022
17639055 HOME CAGE PROGRAMMABLE ACCESS CONTROL DEVICE ALMEIDA BONNIN, ANGELICA ALEJANDRA 3643 §103 Final Rejection — Pending Feb 28, 2022
17410658 THE FGF19-CHOLESTYRAMINE (F-CME) TEST AS A TWO-STAGE METHOD FOR ROUTINE CANCER SCREENING PAK, MICHAEL D 1674 §112 Final Rejection — Pending Aug 24, 2021
17034156 SYSTEM AND METHOD TO REVEAL TEMPERATURE GRADIENTS ACROSS THERMAL BARRIER COATINGS USING PHOSPHOR THERMOMETRY GIBSON, RANDY W 2855 §103§112 Non-Final OA — Pending Sep 28, 2020

Managing University of Central Florida Research Foundation Inc.'s Patent Portfolio?

IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Frequently Asked Questions

How many pending USPTO office actions does University of Central Florida Research Foundation Inc. have?

University of Central Florida Research Foundation Inc. has 22 pending office actions as of October 2026, spread across 20 art units and 22 examiners.

Which USPTO examiner handles the most University of Central Florida Research Foundation Inc. applications?

Michael J Warmflash has the most, with 1 of University of Central Florida Research Foundation Inc.'s pending office actions.

What technology area are University of Central Florida Research Foundation Inc.'s patent applications in?

Mostly Semiconductors, Circuits & Optics (USPTO Tech Center 2800), based on where its pending office actions are examined.

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month